(Q42167610)

17 October 2017

Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study (English)

1 reference

17 October 2017

2

C Scheidt-Nave

1 reference

17 October 2017

Y Du

1

1 reference

17 October 2017

A Schaffrath Rosario

3

1 reference

17 October 2017

U Ellert

4

1 reference

17 October 2017

M Dören

5

1 reference

17 October 2017

H Knopf

6

1 reference

17 October 2017

1 August 2009

1 reference

17 October 2017

1 reference

17 October 2017

12

1 reference

17 October 2017

4

1 reference

17 October 2017

329-340

1 reference

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

17 October 2017

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Decline in use of hormone therapy among postmenopausal women in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Predictors of difficulty when discontinuing postmenopausal hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Hormone replacement therapy in Germany: determinants and possible health-related outcomes. Results of National Health Surveys from 1984 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Hormones down under: hormone therapy use after the Women's Health Initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Hormone therapy prescribing patterns in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Failure of estrogen plus progestin therapy for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Phytoestrogens for treatment of menopausal symptoms: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Recent reversal of trends in hormone therapy use in a European population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Brief report: attitudes toward hormone therapy after the Women's Health Initiative: a comparison of internists and gynecologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130902745120

10.1080/13697130902745120

21 January 2018

Identifiers

DOI

1 reference

17 October 2017

1 reference